Literature DB >> 10553262

Infections in recipients of blood and marrow transplantation.

J A van Burik1, D J Weisdorf.   

Abstract

The approach to infections in blood and marrow transplant (BMT) recipients involves an understanding of clinical infection syndromes and the natural history of individual infections, taken in the context of patterns of immunosuppression after transplantation and mechanisms underlying immune system reconstitution over time. The conditioning regimen used to prepare the host is a major determinant of host tissue injury and may lead to mucositis or diarrhea, facilitating transmucosal origin of bloodstream infections. Infectious risk also differs between autologous and allogeneic grafts as a consequence of ongoing immunosuppression from graft-versus-host disease and its therapy. Post-transplant complications may mimic infectious processes, and multiple infections may occur in one patient at the same time. Thus, the BMT patient with suspected infection should be evaluated in the context of pretransplant exposure history (infectious disease serologies), conditioning regimen, available culture data from nonsterile mucosal surfaces, previous and recent infections, contemporary transplant complications, and the current degree and duration of neutropenia, cellular immunodeficiency, and hypogammaglobulinemia.

Entities:  

Mesh:

Year:  1999        PMID: 10553262     DOI: 10.1016/s0889-8588(05)70110-6

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  3 in total

Review 1.  Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.

Authors:  Christopher C Dvorak; Brian T Fisher; Lillian Sung; William J Steinbach; Michael Nieder; Sarah Alexander; Theoklis E Zaoutis
Journal:  Pediatr Blood Cancer       Date:  2011-11-18       Impact factor: 3.167

2.  Nonparametric methods for analyzing recurrent gap time data with application to infections after hematopoietic cell transplant.

Authors:  Chi Hyun Lee; Xianghua Luo; Chiung-Yu Huang; Todd E DeFor; Claudio G Brunstein; Daniel J Weisdorf
Journal:  Biometrics       Date:  2015-11-17       Impact factor: 2.571

3.  Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation.

Authors:  Agnieszka Czechowicz; Rahul Palchaudhuri; Amelia Scheck; Yu Hu; Jonathan Hoggatt; Borja Saez; Wendy W Pang; Michael K Mansour; Tiffany A Tate; Yan Yi Chan; Emily Walck; Gerlinde Wernig; Judith A Shizuru; Florian Winau; David T Scadden; Derrick J Rossi
Journal:  Nat Commun       Date:  2019-02-06       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.